Your browser doesn't support javascript.
loading
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
Esmail, Aliasgar; Oelofse, Suzette; Lombard, Carl; Perumal, Rubeshan; Mbuthini, Linda; Goolam Mahomed, Akhter; Variava, Ebrahim; Black, John; Oluboyo, Patrick; Gwentshu, Nelile; Ngam, Eric; Ackerman, Tertius; Marais, Linde; Mottay, Lynelle; Meier, Stuart; Pooran, Anil; Tomasicchio, Michele; Te Riele, Julian; Derendinger, Brigitta; Ndjeka, Norbert; Maartens, Gary; Warren, Robin; Martinson, Neil; Dheda, Keertan.
Affiliation
  • Esmail A; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Oelofse S; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council, and.
  • Lombard C; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Perumal R; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council, and.
  • Mbuthini L; Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.
  • Goolam Mahomed A; Division of Epidemiology and Biostatistics, Department of Global Health, University of Stellenbosch, Cape Town, South Africa.
  • Variava E; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Black J; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council, and.
  • Oluboyo P; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Gwentshu N; Department of Intensive Care, Medunsa Campus, Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa.
  • Ngam E; Department of Internal Medicine, and.
  • Ackerman T; Department of Health, North West Province, Mahikeng, South Africa.
  • Marais L; Perinatal HIV Research Unit, Soweto, South Africa.
  • Mottay L; Department of Internal Medicine, Livingstone Tertiary Hospital, Walter Sisulu University, Gqeberha, South Africa.
  • Meier S; Department of Medicine, Head of Pulmonology, Nelson Mandela Academic Hospital, Walter Sisulu University, Mthatha, South Africa.
  • Pooran A; Don Makenzie Hospital, Durban, South Africa.
  • Tomasicchio M; Don Makenzie Hospital, Durban, South Africa.
  • Te Riele J; Harry Comay Hospital, George, South Africa.
  • Derendinger B; Harry Comay Hospital, George, South Africa.
  • Ndjeka N; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Maartens G; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council, and.
  • Warren R; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Martinson N; Centre for the Study of Antimicrobial Resistance, South African Medical Research Council, and.
  • Dheda K; Division of Pulmonology, Department of Medicine, Centre for Lung Infection and Immunity, University of Cape Town Lung Institute, Cape Town, South Africa.
Am J Respir Crit Care Med ; 205(10): 1214-1227, 2022 05 15.
Article in En | MEDLINE | ID: mdl-35175905

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Document type: Article Affiliation country: South Africa Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2022 Document type: Article Affiliation country: South Africa Country of publication: United States